Factor Therapeutics Ltd (FTT)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Factor Therapeutics Ltd (FTT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011683
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Factor Therapeutics Ltd (FTL), formerly Tissue Therapies Ltd is a developer of wound care therapeutics. The company develops treatments for acute and chronic wound healing applications such as chronic skin ulcers and burns. Its lead therapeutic candidate, VF-001 is a targeted growth factor which is being developed to treat venous leg ulcers. FTL offers cell culture reagents to enhance the growth of mammalian cells for cell-based therapies. The company’s VF-001 pursues the development of other product candidates which may be applicability to other wound care applications. It utilizes third parties for development and commercialization of its novel products. FTL is headquartered in Brisbane, Queensland, Australia.

Factor Therapeutics Ltd (FTT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Factor Therapeutics Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Factor Therapeutics Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Factor Therapeutics Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Factor Therapeutics Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Factor Therapeutics Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Factor Therapeutics Ltd, Medical Equipment, Deal Details 10
Equity Offering 10
Tissue Therapies Completes Rights Offering Of Shares For US$4.5 Million 10
Tissue Therapies Announces Private Placement Of Shares For US$0.5 Million 12
Tissue Therapies Completes Private Placement Of Shares For US$3 Million 13
Tissue Therapies Announces Private Placement Of Shares For US$1.2 Million 15
Factor Therapeutics Ltd – Key Competitors 16
Factor Therapeutics Ltd – Key Employees 17
Factor Therapeutics Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Corporate Communications 19
Aug 03, 2016: Factor Therapeutics: Formation of Medical Advisory Board 19
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Factor Therapeutics Ltd, Medical Equipment, Key Facts, 2017 2
Factor Therapeutics Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Factor Therapeutics Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Factor Therapeutics Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Factor Therapeutics Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Factor Therapeutics Ltd, Deals By Market, 2011 to YTD 2017 8
Factor Therapeutics Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Tissue Therapies Completes Rights Offering Of Shares For US$4.5 Million 10
Tissue Therapies Announces Private Placement Of Shares For US$0.5 Million 12
Tissue Therapies Completes Private Placement Of Shares For US$3 Million 13
Tissue Therapies Announces Private Placement Of Shares For US$1.2 Million 15
Factor Therapeutics Ltd, Key Competitors 16
Factor Therapeutics Ltd, Key Employees 17
Factor Therapeutics Ltd, Other Locations 18
Factor Therapeutics Ltd, Subsidiaries 18

★海外企業調査レポート[Factor Therapeutics Ltd (FTT)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Samudera Shipping Line Ltd. (S56):企業概要、財務及び戦略的SWOT分析
    Summary Samudera Shipping Line Ltd (Samudera) is a shipping service company. The company operates in three service segments, such as Container shipping, Industrial shipping, and Logistic. It provides container shipping services, such as feeder and liner. Samudera provides the feeder services to main …
  • Oculus VisionTech Inc. (OVT):企業概要、財務及び戦略的SWOT分析
    Summary Oculus VisionTech Inc. (Oculus) is an information technology company. The company designs, develops and markets digital watermarking, streaming video and video-on-demand systems, services and source-to-destination digital media delivery solutions. Its products include MediaEscort and MediaEs …
  • Aozora Bank, Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Aozora Bank, Ltd. Mergers and A …
  • Oncology Venture ApS-製薬・医療分野:企業M&A・提携分析
    Summary Oncology Venture ApS (Oncology Venture), a subsidiary of Oncology Venture Sweden AB is a drug development company that discovers new oncology products, and rescuing failed ones. The company provides gene-tumor-technology for identifying patients with resistance to anticancer drug. Its activi …
  • Genable Technologies Ltd:企業のM&A・提携動向(医療分野)
    Summary Genable Technologies Ltd (Spark) formerly Genable Technologies Limited is a biopharmaceutical company that discovers, manufactures and distributes new gene therapies for the treatment of inherited genetic disorders. The company is developing gene based therapies for the treatment of heredita …
  • SMRT Corporation Ltd.:企業の戦略・SWOT・財務分析
    SummarySMRT Corporation Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key F …
  • OAO OPK “Oboronprom”:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' OAO OPK "Oboronprom" Mergers an …
  • Fujirebio Inc.:企業のM&A・提携動向(医療機器分野)
    Summary Fujirebio Inc. (Fujirebio), a subsidiary of Miraca Holdings Inc is a medical device company which manufactures and exports reagents and equipments for clinical diagnostics and assay systems. The company’s products include serodia series, automated analyzer system and MSDS, among others. Fuji …
  • Siegfried Holding AG (SFZN)-製薬・医療分野:企業M&A・提携分析
    Summary Siegfried Holding AG (Siegfried) is a custom manufacturing organization (CMO). The company is active in the primary and secondary production of drugs. It develops and manufactures active pharmaceutical ingredients (APIs) for the research-based pharmaceutical industry and corresponding interm …
  • KION Group AG:企業の戦略・SWOT・財務分析
    SummaryKION Group AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings …
  • Saline Water Conversion Corp:企業の戦略的SWOT分析
    Saline Water Conversion Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • PT Wijaya Karya (Persero) Tbk:企業の戦略・SWOT・財務分析
    SummaryPT Wijaya Karya (Persero) Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the compan …
  • Transfield Services Limited (TSE):企業のM&A・提携動向(エネルギー分野)
    Summary Transfield Services Limited (Transfield) is a provider of construction and allied services. The company offers operations, maintenance, asset management, engineering, construction management, consulting, project and program management services, and infrastructure development services. It ope …
  • Medicrea International SA (ALMED):企業概要、財務及び戦略的SWOT分析
    Summary Medicrea International SA (Medicrea) is a medical device company. The company designs, manufactures and distributes implant systems and surgical instruments for spine surgery. It offers PASS range products such as PASS LP, LIGAPASS and PASS ANT. Medicrea provides CERVICAL range products such …
  • Merus Labs International, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Merus Labs International, Inc. …
  • Trinidad Drilling Ltd. (TDG):企業財務及び戦略的SWOT分析
    Summary Trinidad Drilling Ltd. (Trinidad Drilling) is an oil and gas company that offers land and barge drilling, and coring and presetting services. The company’s services include drilling, well servicing, rig fleet, coring and pre-setting, and manufacturing and technology. Its in-house manufacturi …
  • Envision Healthcare Corp:戦略・SWOT・企業財務分析
    Envision Healthcare Corp - Strategy, SWOT and Corporate Finance Report Summary Envision Healthcare Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Pizza Pizza Limited :企業の戦略・SWOT・財務分析
    SummaryPizza Pizza Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Fin …
  • Baxter International Inc (BAX):企業のM&A・提携動向(医療分野)
    Summary Baxter International Inc (Baxter) is one of the leading providers of renal and hospital products. It undertakes the development, manufacture and marketing of medical products, which assist healthcare professionals and their patients in the treatment of end-stage renal diseases. Its portfolio …
  • Amara Raja Batteries Ltd (AMARAJABAT):企業財務及び戦略的SWOT分析
    Summary Amara Raja Batteries Ltd (ARBL) is an electric equipment manufacturing company that supplies batteries for automotive and industrial applications. The company provides industrial batteries such as amaron sleek, amaron quanta, amaron volt and power stack industrial batteries. It also offers a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆